Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-042673
Filing Date
2025-03-20
Accepted
2025-03-20 16:15:31
Documents
89
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K asmb-20241231.htm   iXBRL 10-K 2843768
2 EX-4.1 asmb-ex4_1.htm EX-4.1 6228
3 EX-19.1 asmb-ex19_1.htm EX-19.1 77033
4 EX-21.1 asmb-ex21_1.htm EX-21.1 6868
5 EX-23.1 asmb-ex23_1.htm EX-23.1 17076
6 EX-31.1 asmb-ex31_1.htm EX-31.1 16544
7 EX-32.1 asmb-ex32_1.htm EX-32.1 8073
8 GRAPHIC img87312576_0.jpg GRAPHIC 272601
9 GRAPHIC img87312576_1.jpg GRAPHIC 108779
10 GRAPHIC img236136134_0.jpg GRAPHIC 4327
  Complete submission text file 0000950170-25-042673.txt   13013018

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT asmb-20241231.xsd EX-101.SCH 1777237
92 EXTRACTED XBRL INSTANCE DOCUMENT asmb-20241231_htm.xml XML 2344077
Mailing Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address TWO TOWER PLACE 7TH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35005 | Film No.: 25756625
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)